Curtis J R, Bennett C L, Horner R D, Rubenfeld G D, DeHovitz J A, Weinstein R A
Department of Medicine, University of Washington, Seattle, USA.
Crit Care Med. 1998 Apr;26(4):668-75. doi: 10.1097/00003246-199804000-00013.
To determine whether intensive care unit (ICU) use and outcomes for patients with human immunodeficiency virus (HIV)-related Pneumocystis carinii pneumonia vary by hospital characteristics and geographic location.
Retrospective review of the medical records of 2,174 patients with HIV-related P. carinii pneumonia.
Random sample of 73 private, nine public, and 14 Veterans Affairs hospitals in five cities (Chicago, New York, Los Angeles, Miami, and Durham, NC).
Stratified random sample of patients hospitalized with HIV-related P. carinii pneumonia from 1987 to 1990.
None.
Among the 2,174 patients with P. carinii pneumonia, 398 (18%) patients received care in an ICU. ICU utilization varied significantly by patient and hospital characteristics, as well by as geographic location. Non-Hispanic whites, patients with Medicaid, and patients with a prior acquired immunodeficiency syndrome-defining illness were the least likely to receive care in an ICU. Patients in county- or state-owned hospitals and patients in hospitals with more P. carinii pneumonia-experience were also less likely to be cared for in an ICU. These differences in ICU utilization persisted when controlling for severity of illness, as well as other patient characteristics. Significant geographic variation in ICU utilization persisted after controlling for patient and hospital characteristics. Survival to hospital discharge after an ICU stay was significantly higher for patients without a prior acquired immunodeficiency syndrome-defining illness and for patients in hospitals with more P. carinii pneumonia experience.
We found significant variations in ICU utilization by hospital characteristics and geographic location that remained significant after controlling for severity of illness and patient sociodemographic characteristics. Hospital and geographic variations in ICU utilization may make it difficult to generalize ICU outcomes across different hospitals.
确定感染人类免疫缺陷病毒(HIV)相关卡氏肺孢子虫肺炎患者的重症监护病房(ICU)使用情况及预后是否因医院特征和地理位置而异。
对2174例HIV相关卡氏肺孢子虫肺炎患者的病历进行回顾性分析。
从五个城市(芝加哥、纽约、洛杉矶、迈阿密和北卡罗来纳州达勒姆)的73家私立医院、9家公立医院和14家退伍军人事务医院中随机抽取样本。
1987年至1990年因HIV相关卡氏肺孢子虫肺炎住院患者的分层随机样本。
无。
在2174例卡氏肺孢子虫肺炎患者中,398例(18%)在ICU接受治疗。ICU的使用率因患者和医院特征以及地理位置而异。非西班牙裔白人、有医疗补助的患者以及之前患有获得性免疫缺陷综合征定义疾病的患者在ICU接受治疗的可能性最小。县级或州级医院的患者以及有更多卡氏肺孢子虫肺炎治疗经验医院的患者在ICU接受治疗的可能性也较小。在控制疾病严重程度以及其他患者特征后,ICU使用率的这些差异仍然存在。在控制患者和医院特征后,ICU使用率仍存在显著的地理差异。在ICU住院后存活至出院的患者中,之前未患有获得性免疫缺陷综合征定义疾病的患者以及在有更多卡氏肺孢子虫肺炎治疗经验医院的患者存活率显著更高。
我们发现,在控制疾病严重程度和患者社会人口学特征后,ICU使用率因医院特征和地理位置存在显著差异,这些差异仍然显著。ICU使用率的医院和地理差异可能使得难以在不同医院间概括ICU的预后情况。